These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 30697962
1. Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2/STAT3 pathway. Liu K, Tian T, Zheng Y, Zhou L, Dai C, Wang M, Lin S, Deng Y, Hao Q, Zhai Z, Dai Z. J Cell Mol Med; 2019 Apr; 23(4):3040-3044. PubMed ID: 30697962 [Abstract] [Full Text] [Related]
2. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity. Ke Y, Bao T, Wu X, Tang H, Wang Y, Ge J, Fu B, Meng X, Chen L, Zhang C, Tan Y, Chen H, Guo Z, Ni F, Lei X, Shi Z, Wei D, Wang L. Biochem Biophys Res Commun; 2017 Jan 29; 483(1):509-515. PubMed ID: 27998773 [Abstract] [Full Text] [Related]
3. Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway. Xu H, Zhang S. Phytother Res; 2013 Oct 29; 27(10):1524-8. PubMed ID: 23192830 [Abstract] [Full Text] [Related]
4. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells. Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B. Oncol Rep; 2017 Aug 29; 38(2):1224-1232. PubMed ID: 28677802 [Abstract] [Full Text] [Related]
5. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling. Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H. Theranostics; 2019 Aug 29; 9(15):4391-4408. PubMed ID: 31285768 [Abstract] [Full Text] [Related]
6. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway. Wu Y, Yuan T, Wang WW, Ge PL, Gao ZQ, Zhang G, Tang Z, Dang XW, Zhao YF, Zhang JY, Jiang GZ. Cell Physiol Biochem; 2018 Aug 29; 51(1):301-314. PubMed ID: 30453302 [Abstract] [Full Text] [Related]
7. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma. Pei T, Meng Q, Han J, Sun H, Li L, Song R, Sun B, Pan S, Liang D, Liu L. Oncotarget; 2016 Jul 12; 7(28):43475-43491. PubMed ID: 27259268 [Abstract] [Full Text] [Related]
8. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo. Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, Fuchs JE, Shanmugam MK, Dai X, Li F, Deivasigamani A, Hui KM, Kumar AP, Lobie PE, Bender A, Basappa, Sethi G, Rangappa KS. J Biol Chem; 2014 Dec 05; 289(49):34296-307. PubMed ID: 25320076 [Abstract] [Full Text] [Related]
9. Effect of scutellarin on BV-2 microglial-mediated apoptosis in PC12 cells via JAK2/STAT3 signalling pathway. Duan ZD, Zheng LY, Jia QY, Chen HL, Xu DY, Yang YJ, Qi Z, Yang L, Wu CY. Sci Rep; 2024 Jun 11; 14(1):13430. PubMed ID: 38862696 [Abstract] [Full Text] [Related]
10. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma. Wang YD, Sun XJ, Yin JJ, Yin M, Wang W, Nie ZQ, Xu J. Biomed Pharmacother; 2018 Oct 11; 106():134-141. PubMed ID: 29957463 [Abstract] [Full Text] [Related]
11. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway. Li SJ, Sui MH, Sun ZX, Zhang WW. Eur Rev Med Pharmacol Sci; 2019 Feb 11; 23(3):1038-1046. PubMed ID: 30779070 [Abstract] [Full Text] [Related]
12. Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress. Wang Z, Yu J, Wu J, Qi F, Wang H, Wang Z, Xu Z. Life Sci; 2016 Jul 15; 157():200-207. PubMed ID: 26775564 [Abstract] [Full Text] [Related]
13. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway. Gong QZ, Xiao D, Gong GY, Xu J, Wen XD, Feng F, Qu W. Curr Cancer Drug Targets; 2019 Jul 15; 19(7):583-593. PubMed ID: 30585547 [Abstract] [Full Text] [Related]
14. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway. Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, Zhao J, Huang Z, Li Z, Zhou J, Song W, Meng K, Cai J. Oncotarget; 2015 Oct 13; 6(31):31927-43. PubMed ID: 26376676 [Abstract] [Full Text] [Related]
15. NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation. Kang JH, Li MJ, Luan PP, Jiang DK, Chen YW, Xu X, Yu Q, Xu YW, Su Q, Peng WH, Jian WX. Cell Biol Int; 2020 Oct 13; 44(10):2053-2064. PubMed ID: 32584509 [Abstract] [Full Text] [Related]
16. Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway. Wu L, Li J, Liu T, Li S, Feng J, Yu Q, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C. Cancer Med; 2019 Aug 13; 8(10):4806-4820. PubMed ID: 31273958 [Abstract] [Full Text] [Related]
17. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma. Wu J, Xu X, Wu S, Shi W, Zhang G, Cao Y, Wang Z, Wu J, Jiang C. Cancer Med; 2023 Sep 13; 12(17):18078-18097. PubMed ID: 37563971 [Abstract] [Full Text] [Related]
18. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN. Deng W, Han W, Fan T, Wang X, Cheng Z, Wan B, Chen J. Biomed Pharmacother; 2018 Nov 13; 107():1505-1513. PubMed ID: 30257368 [Abstract] [Full Text] [Related]
19. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z. Int J Biochem Cell Biol; 2018 Aug 13; 101():19-28. PubMed ID: 29791864 [Abstract] [Full Text] [Related]
20. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo. Lu HY, Chu HX, Tan YX, Qin XC, Liu MY, Li JD, Ren TS, Zhang YS, Zhao QC. Life Sci; 2020 Mar 01; 244():117343. PubMed ID: 31978449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]